Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis

Atherosclerosis

Volumn 137, Issue SUPPL., 1998, Pages

  Aviram, Michael ^a   Fuhrman, Bianca ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antioxidants; Atherosclerosis; Flavonoids; Lipid peroxidation; Lipoproteins; Macrophages

Indexed keywords

CATECHIN; FLAVONOID; GINGEROL; GLABRIDIN; LOW DENSITY LIPOPROTEIN; POLYPHENOL DERIVATIVE; QUERCETIN;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CONFERENCE PAPER; DIET; FOAM CELL; GLYCYRRHIZA; HUMAN; LIPID PEROXIDATION; MACROPHAGE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; WINE;

ANIMALS; ARTERIOSCLEROSIS; FLAVONOIDS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; PHENOLS;

EID: 0031802390     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00306-7     Document Type: Conference Paper

References (36)

1. Aviram M. Oxidized low density lipoprotein (Ox-LDL) interaction with macrophage in atherosclerosis and the antiatherogenicity of antioxidants. Eur J Clin Chem Clin Biochem 1996;34:599-608.
2. Aviram M. Oxidative modification of low density lipoprotein and atherosclerosis. Isr J Med Sci 1995;31:241-9.
3. Aviram M. LDL-Platelet interaction under oxidative stress induced macrophage foam cell formation. Thromb Haemost 1995;74:560-4.
4. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. New Engl J Med 1989;320:915-24.
5. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms oxidation, inflammation and genetics. Circulation 1995;91:2488-96.
6. Fuhrman B, Oiknine J, Aviram M. Iron induces lipid peroxidation in cultured macrophages increases their ability to oxidatively modify LDL and affect their secretory properties. Atherosclerosis 1994;111:65-78.
7. Fuhrman B, Oiknine J, Keidar S, Kaplan M, Aviram M. Increased uptake of low density lipoprotein (LDL) by oxidized macrophages is the result of enhanced LDL receptor activity and of progressive LDL oxidation. Free Radic Biol Med 1997;23:34-46.
8. Suits AG, Chait A, Aviram M, Heinecke JW. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor dependent foam cell formation. Proc Natl Acad Sci USA 1989;86:2713-7.
9. Heinecke JW, Suits AG, Aviram M, Chait A. Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Sequential morphological and biochemical events. Arteriosclerosis 1991;11:1643-51.
10. Hoff HF, O'Neil J. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler Thromb Vasc Dis 1991;11:1209-22.
11. 2+ -induced oxidation. Biochem J 1995;310:417-26.
12. Maor I, Hayek T, Coleman R, Aviram M. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E deficient mice. Arterioscler Thromb Vasc Dis 1997;17:2995-3005.
13. Yla-Herttuala S, Palinski W, Rosenfeld ME, Pharthasarathy S, Carew TE, Buttler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-95.
14. Aviram M, Maor I, Keidar S, Hayek T, Oiknine J, Bar-E1 Y, Adler Z, Kertzman V, Milo S. Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated. Biochem Biophys Res Commun 1995;216:501-13.
15. Rice Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56.
16. Frankel EN, Kanner J, German J, Parks E, Kinsella JE. Inhibition of human low density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-7.
17. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and LDL to undergo lipid peroxidation. Am J Clin Nutr 1995;61:549-54.
18. Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinki P, Coleman R, Elis A, Aviram M. Reduced progression of atherosclerosis in the apolipoprotein E deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Dis 1997;17:2744-52.
19. Hayek T, Oiknine J, Brook JG, Aviram M. Increased plasma lipoprotein lipid peroxidation in apo E-deficient mice. Biochim Biophys Res Commun 1994;201:1567-74.
20. Fuhrman B, Buch S, Vaya J, Belinky PA, Coleman R, Hayck T, Aviram M. Licorice etanolic extract and its major polyphenol glabridin protect LDL against lipid peroxidation: in vitro and ex-vivo studies in humans and in the atherosclerotic apolipoprotein E deficient mice. Am J Clin Nutr 1997;66:267-75.
21. Vaya J, Belinki P, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity towards LDL oxidation. Free Radic Biol Med 1997;23:302-13.
22. Aviram M, Kasem E. Dietary olive oil reduces the susceptibility of low density lipoprotein to lipid peroxidation and inhibits lipoprotein uptake by macrophages. Ann Nutr Metab 1993;37:75-84.
23. Aviram M, Rosenblat M. Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. J Lipid Res 1994;35:385-98.
24. Aviram M, Rosenblat M, Etzioni A, Levy R. Activation of NADPH oxidase but not of 15-lipoxygenase by low density lipoprotein (LDL) in the presence of copper ions is required for LDL oxidation by macrophages. Metabolism 1996;45:1069-79.
25. Navab M, Berliner JA, Watson AD, Kama SY, Tentto MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM. The Yin and Yang of oxidation in the development of the fatty streak. Arterioscler Thromb Vasc Biol 1996;16:831-42.
26. Rosenblat M, Aviram M. Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL. Free Radic Biol Med 1997;24:305-17.
27. Siess MH, Guillermic M, Le Bon AM, Suschetet M. Induction of monooxygenase and transferase activities in rat by dietary administration of flavonoids. Xenobiotica 1989;19:1379-86.
28. Lindahl M, Tagesson C. Selective inhibition of groups II phospholipase A2 by quercetin. Inflammation 1993;17:537-82.
29. Robak J, Shridi F, Wolbis M, Krolikowska M. Screening of the influence of flavonoids on lipoxygenase and cyclooxygenase activity, as well as on nonenzymic lipid oxidation. Polish J Pharmacol Pharm 1988;40:451-8.
30. Sogawa S, Nihro Y, Ueda H, Izumi A, Miki T, Matsumoto H, Satoh T. 3,4-Hydroxy chalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors. J Med Chem 1993;36:3904-9.
31. Elliot AJ, Scheiber SA, Thomas C, Pardini RS. Inhibition of glutathione reductase by flavonoids. A structure-activity study. Biochem Pharmacol 1992;44:1603-8.
32. Chang WS, Lee YJ, Lu FJ, Chiang HC. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res 1993;13:2165-70.
33. Pincemail J, Thirion A, Dupuis M, Braquet P, Drieu K, Deby C. Ginkgo biloba inhibits oxygen species production generated by phorbol myristate acetate stimulated human leukocytes. Experientia 1987;43:181-4.
34. Nardini M, D'Aquino M, Tomassi G, Gentili V, Di Felice M, Scaccini C. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radic Biol Med 1995;19:541-52.
35. Dushkin MI, Zykov AA, Pivovarova EN. The effect of natural polyphenol compounds on the oxidative modification of low-density lipoproteins. Russian Biull Eksp Biol Med 1993;116:393-5.
36. Pearson DA, Frankel EN, Aeschbach R, German BJ. Inhibition of endothelial cell-mediated oxidation of low density lipoprotein by rosemary and plant phenolics. J Agric Food Chem 1997;45:578-82.